Sitagliptin (JANUVIA®)

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Kafrelsheikh University

Conditions

Diabetes Mellitus, Type 2Liver Cirrhosis With Diabetes

Phase 4

Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis

CompletedNCT07439536

Kafrelsheikh UniversityLiver Cirrhosis With Diabetes

Start: 2024-07-01End: 2025-10-01Updated: 2026-02-27

Unknown Phase

A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)

CompletedNCT01354990

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2009-02-28End: 2010-05-31Updated: 2015-08-27